We are live on ! Find out more
SLXNW

Silexion Therapeutics Warrant
SLXNW

26 hedge funds and large institutions have $91.7K invested in Silexion Therapeutics Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

23.55% more ownership

Funds ownership: 0% → 23.55% (+24%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

14% less capital invested

Capital invested by funds: $106K → $91.7K (-$14.4K)

16% less funds holding

Funds holding: 31 → 26 (-5)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
26
Holders Change
-5
Holders Change %
-16.13%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
6
Calls
$29K
Puts
–
Net Calls
+$29K
Net Calls Change
+$21K

Top Buyers

Rank Fund Capital Flow
1
GS
GTS Securities
New York
+$945
2
Walleye Trading
Walleye Trading
New York
+$844
3
Goldman Sachs
Goldman Sachs
New York
+$570
4
CS
Clear Street
New York
+$338
5
Bank of America
Bank of America
North Carolina
+$7

Top Sellers

Rank Fund Capital Flow
1
GCIA
Gabelli & Co Investment Advisers
New York
-$1.21K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.1K
3
GF
Gabelli Funds
New York
-$967
4
PC
Periscope Capital
Ontario, Canada
-$698
5
Walleye Capital
Walleye Capital
New York
-$666
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$25.5K – – –
LA
2
Linden Advisors
New York
$13.8K – – –
AC
3
Aristeia Capital
Connecticut
$9.9K – – –
HP
4
Hartree Partners
New York
$5.63K – – –
SBLIC
5
Security Benefit Life Insurance Company
Kansas
$5.04K – – –
CS
6
Clear Street
New York
$4.93K +$338 +8,404 +6%
Goldman Sachs
7
Goldman Sachs
New York
$3.64K +$570 +14,188 +15%
KC
8
Kepos Capital
New York
$3K – – –
PC
9
Periscope Capital
Ontario, Canada
$2.96K -$698 -17,374 -17%
Jane Street
10
Jane Street
New York
$2.57K – – –
YCM
11
Yakira Capital Management
Connecticut
$2.54K – – –
CCM
12
Context Capital Management
California
$1.74K -$444 -11,055 -18%
TCM
13
Tenor Capital Management
New York
$1.7K – – –
Walleye Trading
14
Walleye Trading
New York
$1.19K +$844 +21,000 +150%
DCM
15
Dupont Capital Management
Delaware
$1.1K – – –
Neuberger Berman Group
16
Neuberger Berman Group
New York
$1.07K – – –
MTCM
17
Mint Tower Capital Management
Netherlands
$1K – – –
PMAM
18
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
GS
19
GTS Securities
New York
$799 +$945 +23,498 New
Stifel Financial
20
Stifel Financial
Missouri
$542 – – –
RCM
21
Rivernorth Capital Management
Florida
$508 – – –
SCM
22
Saba Capital Management
New York
$488 – – –
Citadel Advisors
23
Citadel Advisors
Florida
$456 -$194 -4,825 -26%
CCA
24
Cobblestone Capital Advisors
New York
$339 – – –
WAM
25
Wolverine Asset Management
Illinois
$296 -$48 -1,200 -12%
1
2

SLXNW Hedge Fund Activity: Q4 2024 in Review

26 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q4 2024, worth a combined $91.7K — down 14% from $106K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SLXNW and 1 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was GTS Securities, opening a new position worth an estimated $945. The largest seller was Gabelli & Co Investment Advisers, exiting entirely with an estimated $1.21K sold.

  • 26 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q4 2024, down from 31 in Q3 2024.
  • Funds reported $91.7K of Silexion Therapeutics Warrant stock for Q4 2024, down 14% quarter-over-quarter.
  • 1 fund opened new Silexion Therapeutics Warrant positions in Q4 2024 and 6 closed out, a net change of -5 holders.
  • The largest Silexion Therapeutics Warrant buyer in Q4 2024 was GTS Securities, an estimated $945 added.
  • The largest Silexion Therapeutics Warrant seller in Q4 2024 was Gabelli & Co Investment Advisers, an estimated $1.21K sold.

Based on aggregated 13F filings for Q4 2024.